World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
92
Citations
30650
World Ranking
11317
National Ranking
5808

Overview

Fred G. Barker is affiliated with Harvard University in the United States. Their research primarily focuses on the field of Medicine, with significant contributions in subfields such as Neurology, Genetics, Epidemiology, Pulmonary and Respiratory Medicine, and Surgery.

Key topics in Barker's scholarly work include:

  • Glioma Diagnosis and Treatment
  • Meningioma and schwannoma management
  • Neurofibromatosis and Schwannoma Cases
  • Pituitary Gland Disorders and Treatments
  • Brain Metastases and Treatment
  • Bone Tumor Diagnosis and Treatments
  • Chromatin Remodeling and Cancer

Barker has published extensively in several prominent journals and venues. Frequent publication venues include:

  • Neuro-Oncology
  • Neurosurgery
  • Journal of neurosurgery
  • International Journal of Radiation Oncology*Biology*Physics
  • Blood

Recent papers authored or co-authored by Barker cover a range of topics related to genetic and neurological disorders as well as surgical outcomes. Notable recent publications include:

  • "Revised diagnostic criteria for neurofibromatosis type 1 and Legius syndrome: an international consensus recommendation" (2021, Genetics in Medicine)
  • "Updated diagnostic criteria and nomenclature for neurofibromatosis type 2 and schwannomatosis: An international consensus recommendation" (2022, Genetics in Medicine)
  • "Effect of Ventral vs Dorsal Spinal Surgery on Patient-Reported Physical Functioning in Patients With Cervical Spondylotic Myelopathy" (2021, JAMA)
  • "BRAF-MEK Inhibition in Newly Diagnosed Papillary Craniopharyngiomas" (2023, New England Journal of Medicine)
  • "Distinct genomic subclasses of high-grade/progressive meningiomas: NF2-associated, NF2-exclusive, and NF2-agnostic" (2020, Acta Neuropathologica Communications)

Frequent co-authors in Barker's collaborations include:

  • Priscilla K. Brastianos
  • William T. Curry
  • Daniel P. Cahill
  • Justin T. Jordan
  • Anat Stemmer-Rachamimov

The research output reflects a breadth of expertise encompassing diagnosis, treatment, and molecular characteristics of neurological tumors and associated syndromes. Barker's work contributes to advancing knowledge in neuro-oncology, neurosurgery, and genetics, particularly in delineating diagnostic criteria and treatment responses across complex brain and spinal conditions.

Best Publications

  • The long-term outcome of microvascular decompression for trigeminal neuralgia

    Fred G. Barker;Peter J. Jannetta;David J. Bissonette;Mark V. Larkins

  • Effect of Radiosurgery Alone vs Radiosurgery With Whole Brain Radiation Therapy on Cognitive Function in Patients With 1 to 3 Brain Metastases: A Randomized Clinical Trial

    Paul D. Brown;Kurt Jaeckle;Karla V. Ballman;Elana Farace

  • Postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease (NCCTG N107C/CEC·3): a multicentre, randomised, controlled, phase 3 trial

    Paul D. Brown;Paul D. Brown;Karla V. Ballman;Karla V. Ballman;Jane H. Cerhan;S. Keith Anderson

  • Genomic Characterization of Brain Metastases Reveals Branched Evolution and Potential Therapeutic Targets

    Priscilla K. Brastianos;Scott L. Carter;Scott L. Carter;Sandro Santagata;Sandro Santagata;Daniel P. Cahill

  • Long-term mortality after transsphenoidal surgery and adjunctive therapy for acromegaly

    Brooke Swearingen;Fred G. Barker;Laurence Katznelson;Beverly M. K. Biller

  • Laminectomy plus Fusion versus Laminectomy Alone for Lumbar Spondylolisthesis

    Zoher Ghogawala;James Dziura;William E. Butler;Feng Dai

  • Transsphenoidal surgery for pituitary tumors in the United States, 1996-2000: mortality, morbidity, and the effects of hospital and surgeon volume.

    Fred G. Barker;Anne Klibanski;Brooke Swearingen

  • Hearing Improvement after Bevacizumab in Patients with Neurofibromatosis Type 2

    Scott R. Plotkin;Anat O. Stemmer-Rachamimov;Fred G. Barker;Chris Halpin

  • Microvascular decompression for hemifacial spasm

    Fred G. Barker;Peter J. Jannetta;David J. Bissonette;Philip T. Shields

  • A Phase I Open-Label, Dose-Escalation, Multi-Institutional Trial of Injection with an E1B-Attenuated Adenovirus, ONYX-015, into the Peritumoral Region of Recurrent Malignant Gliomas, in the Adjuvant Setting

    E. Antonio Chiocca;Khalid M. Abbed;Stephen Tatter;David N. Louis

  • Long-term recurrence rates of atypical meningiomas after gross total resection with or without postoperative adjuvant radiation.

    Manish K. Aghi;Bob S. Carter;Garth R. Cosgrove;Robert G. Ojemann

  • Revised diagnostic criteria for neurofibromatosis type 1 and Legius syndrome: an international consensus recommendation.

    E Legius;L Messiaen;P Wolkenstein;P Pancza

  • Efficacy of prophylactic nimodipine for delayed ischemic deficit after subarachnoid hemorrhage: a metaanalysis

    Fred G. Barker;Christopher S. Ogilvy

  • Survival and Functional Status after Resection of Recurrent Glioblastoma Multiforme

    Fred G. Barker;Susan M. Chang;Philip H. Gutin;Mary K. Malec

  • Microvascular decompression surgery in the United States, 1996 to 2000: mortality rates, morbidity rates, and the effects of hospital and surgeon volumes.

    Steven N. Kalkanis;Emad N. Eskandar;Bob S. Carter;Fred G. Barker

  • Epidermal Growth Factor Receptor Variant III Status Defines Clinically Distinct Subtypes of Glioblastoma

    Christopher E. Pelloski;Karla V. Ballman;Alfred F. Furth;Li Zhang

  • Analysis of complex relationships between age, p53, epidermal growth factor receptor, and survival in glioblastoma patients.

    Martha L. Simmons;Kathleen R. Lamborn;Michelle Takahashi;Pengchin Chen

  • EGFR overexpression and radiation response in glioblastoma multiforme.

    Fred G. Barker;Fred G. Barker;Martha L. Simmons;Susan M. Chang;Michael D. Prados

  • Perioperative complications and neurological outcomes of first and second craniotomies among patients enrolled in the Glioma Outcome Project

    Susan M. Chang;Ian F. Parney;Michael McDermott;Fred G. Barker

  • Long-term mortality after transsphenoidal surgery for Cushing disease.

    Brooke Swearingen;Beverly M.K. Biller;Fred G. Barker;Laurence Katznelson

Frequent Co-Authors

Bob S. Carter
Bob S. Carter Harvard University
Jay S. Loeffler
Jay S. Loeffler Harvard University
Paul D. Brown
Paul D. Brown Mayo Clinic
Robert L. Martuza
Robert L. Martuza Harvard Medical School
Sandro Santagata
Sandro Santagata Brigham and Women's Hospital
Karla V. Ballman
Karla V. Ballman Cornell University
Michael J. McKenna
Michael J. McKenna Massachusetts Eye and Ear Infirmary
David N. Louis
David N. Louis Harvard University
Christopher S. Ogilvy
Christopher S. Ogilvy Beth Israel Deaconess Medical Center
Susan M. Chang
Susan M. Chang University of California, San Francisco

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring careers in medicine goes beyond traditional medical school routes. Today, online healthcare degrees are more accessible and affordable than ever, offering students flexible ways to enter the medical field or advance existing careers. For those interested in administrative roles, medical billing and coding online courses cost far less than many traditional programs, helping students acquire in-demand skills quickly and affordably.

If direct patient care is your goal, online nursing programs allow you to earn an accredited nursing degree while working or managing other responsibilities. Those seeking advanced clinical roles can explore affordable np programs, which qualify graduates as nurse practitioners — one of the fastest-growing healthcare careers.

For nurses pursuing leadership or research in healthcare, phd nursing programs are also increasingly available online, opening doors for academic, policy, and advanced clinical roles. These pathways make it possible to tailor your education and career to your specific interests within the medical industry.

Best Scientists Citing Fred G. Barker

Trending Scientists